ConductScience.org, home

Paper41295464

A Multiplex Serological Assay to Evaluate the Antibody Responses to a Set of Plasmodium falciparum Antigens and Their Protective Role Against Malaria in Children Aged 1.5 to 12 Years Living in a Highly Seasonal Malaria Transmission Area of Burkina Faso.

Ezinmegnon S and 10 others. Vaccines (Basel), 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. A Multiplex Serological Assay to Evaluate the Antibody Responses to a Set of Plasmodium falciparum Antigens and Their Protective Role Against Malaria in Children Aged 1.5 to 12 Years Living in a Highly Seasonal Malaria Transmission Area of Burkina Faso. Papers, record 41295464. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41295464

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Multiplex Serological Assay to Evaluate the Antibody Responses to a Set of Plasmodium falciparum Antigens and Their Protective Role Against Malaria in Children Aged 1.5 to 12 Years Living in a Highly Seasonal Malaria Transmission Area of Burkina Faso.
PubMed
Journal
Vaccines (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-11-28
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ezinmegnon SSem
2Nébié IIssahttps://orcid.org/0000-0003-3051-3600
3Marlais TTegwenhttps://orcid.org/0000-0003-0955-9807
4Ouattara DDaouda
5Diarra AAmidouhttps://orcid.org/0009-0000-3426-1012
6Patterson CCatriona
7Tetteh KKevinhttps://orcid.org/0000-0003-2733-0037
8Ouédraogo AAlphonsehttps://orcid.org/0000-0002-3520-6637
9Drakeley CChris
10Tiono ABAlfred Bhttps://orcid.org/0000-0002-5104-3946
11Sirima SBSodiomon Bhttps://orcid.org/0000-0002-0972-4211

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136605129RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.Front Cell Infect Microbiol2022https://conductscience.org/library/papers/36605129PubMed
237693871Analytical approaches for antimalarial antibody responses to confirm historical and recent malaria transmission: an example from the Philippines.Lancet Reg Health West Pac2023https://conductscience.org/library/papers/37693871PubMed
332127565Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination.Sci Rep2020https://conductscience.org/library/papers/32127565PubMed
438310910Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.Lancet2024https://conductscience.org/library/papers/38310910PubMed
537612716Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report.Malar J2023https://conductscience.org/library/papers/37612716PubMed
625927360Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.PLoS One2015https://conductscience.org/library/papers/25927360PubMed
716515510Immune responses to asexual blood-stages of malaria parasites.Curr Mol Med2006https://conductscience.org/library/papers/16515510PubMed
828646586Vaccine candidate discovery for the next generation of malaria vaccines.Immunology2017https://conductscience.org/library/papers/28646586PubMed
923473542Influence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda.Parasite Immunol2013https://conductscience.org/library/papers/23473542PubMed
1035524310Assessing the effect of seasonal malaria chemoprevention on malaria burden among children under 5 years in Burkina Faso.Malar J2022https://conductscience.org/library/papers/35524310PubMed
1123861883Antibodies to polymorphic invasion-inhibitory and non-Inhibitory epitopes of Plasmodium falciparum apical membrane antigen 1 in human malaria.PLoS One2013https://conductscience.org/library/papers/23861883PubMed
1220140214Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.PLoS One2010https://conductscience.org/library/papers/20140214PubMed
1332972398
Antibody responses to a suite of novel serological markers for malaria surveillance demonstrate strong correlation with clinical and parasitological infection across seasons and transmission settings in The Gambia.
BMC Med2020https://conductscience.org/library/papers/32972398PubMed
1434357982Naturally Acquired Antibodies against Plasmodium falciparum: Friend or Foe?Pathogens2021https://conductscience.org/library/papers/34357982PubMed
1534182772Protein Prenylation and Hsp40 in Thermotolerance of Plasmodium falciparum Malaria Parasites.mBio2021https://conductscience.org/library/papers/34182772PubMed
1621949716A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720.PLoS One2011https://conductscience.org/library/papers/21949716PubMed
1731849871Plasmodium falciparum Blood Stage Antimalarial Vaccines: An Analysis of Ongoing Clinical Trials and New Perspectives Related to Synthetic Vaccines.Front Microbiol2019https://conductscience.org/library/papers/31849871PubMed
1839018754Diversity and selection analyses identify transmission-blocking antigens as the optimal vaccine candidates in Plasmodium falciparum.EBioMedicine2024https://conductscience.org/library/papers/39018754PubMed
193514142510-year longitudinal study of malaria in children: Insights into acquisition and maintenance of naturally acquired immunity.Wellcome Open Res2021https://conductscience.org/library/papers/35141425PubMed
2035198913
Serological evaluation of the effectiveness of reactive focal mass drug administration and reactive vector control to reduce malaria transmission in Zambezi Region, Namibia: Results from a secondary analysis of a cluster randomised trial.
EClinicalMedicine2022https://conductscience.org/library/papers/35198913PubMed

See all 42 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42093919Malaria antibody responses augment surveillance in low-transmission settings in the Upper River Region, the Gambia.Front Epidemiol2026https://conductscience.org/library/papers/42093919

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
DNAJB1P1171221PubTator's text mininghttps://conductscience.org/library/genes/171221NCBI Gene
DNAJC580331PubTator's text mininghttps://conductscience.org/library/genes/80331NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41295464

GET https://conductscience.org/api/papers/v1/41295464/references?page=2